Globus Medical (GMED) - Total Assets
Based on the latest financial reports, Globus Medical (GMED) holds total assets worth $5.30 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Globus Medical book value and equity for net asset value and shareholders' equity analysis.
Globus Medical - Total Assets Trend (2010–2025)
This chart illustrates how Globus Medical's total assets have evolved over time, based on quarterly financial data.
Globus Medical - Asset Composition Analysis
Current Asset Composition (December 2025)
Globus Medical's total assets of $5.30 Billion consist of 40.1% current assets and 59.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.9% |
| Accounts Receivable | $678.94 Million | 12.8% |
| Inventory | $759.28 Million | 14.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $745.06 Million | 14.1% |
| Goodwill | $1.44 Billion | 27.1% |
Asset Composition Trend (2010–2025)
This chart illustrates how Globus Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Globus Medical (GMED) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Globus Medical's current assets represent 40.1% of total assets in 2025, a decrease from 82.1% in 2010.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2025, down from 41.9% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is goodwill at 27.1% of total assets.
Globus Medical Competitors by Total Assets
Key competitors of Globus Medical based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Globus Medical - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.26 | 2.54 | 6.58 |
| Quick Ratio | 2.74 | 1.77 | 4.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.63 Billion | $1.32 Billion | $690.70 Million |
Globus Medical - Advanced Valuation Insights
This section examines the relationship between Globus Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.60 |
| Latest Market Cap to Assets Ratio | 2.33 |
| Asset Growth Rate (YoY) | 1.0% |
| Total Assets | $5.30 Billion |
| Market Capitalization | $12.35 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Globus Medical's assets at a significant premium (2.33x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Globus Medical's assets grew by 1.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Globus Medical (2010–2025)
The table below shows the annual total assets of Globus Medical from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $5.30 Billion | +0.97% |
| 2024-12-31 | $5.25 Billion | +3.26% |
| 2023-12-31 | $5.09 Billion | +144.98% |
| 2022-12-31 | $2.08 Billion | +6.07% |
| 2021-12-31 | $1.96 Billion | +16.54% |
| 2020-12-31 | $1.68 Billion | +9.62% |
| 2019-12-31 | $1.53 Billion | +17.79% |
| 2018-12-31 | $1.30 Billion | +20.60% |
| 2017-12-31 | $1.08 Billion | +16.26% |
| 2016-12-31 | $927.64 Million | +11.21% |
| 2015-12-31 | $834.10 Million | +18.56% |
| 2014-12-31 | $703.55 Million | +24.23% |
| 2013-12-31 | $566.30 Million | +26.65% |
| 2012-12-31 | $447.13 Million | +35.75% |
| 2011-12-31 | $329.39 Million | +23.56% |
| 2010-12-31 | $266.57 Million | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more